Business Context and Reporting Period
This Form 6-K filing by Legend Biotech Corporation is dated August 18, 2026. The report serves as a notification that the Company will hold its Annual General Meeting of Shareholders on September 24, 2026, at 9:00 a.m. local time at its principal executive office in Bridgewater, New Jersey.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the scheduling of the Annual General Meeting and the availability of related materials.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It notes that materials related to the meeting are available on the Company's website but explicitly states that website information is not part of this filing. The report incorporates by reference the Proxy Statement (Exhibit 99.1), Notice of Annual General Meeting (Exhibit 99.2), Form of Proxy (Exhibit 99.3), and Voting Card (Exhibit 99.4).
Investor Verification Checklist
- Verify the date and location of the Annual General Meeting (September 24, 2026, Bridgewater, NJ).
- Review the attached Proxy Statement (Exhibit 99.1) for detailed governance and voting matters.
- Confirm the identity of the signatory, Alan Bash, listed as Interim Chief Executive Officer.
- Check the Company's website for meeting materials, noting they are not incorporated into this specific filing.